BAERGIC BIO ⎸2
Forward Looking Statements
This presentation may contain “forward-looking statements” within the meaning of Section 27A of the
Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, as amended. Such
statements include, but are not limited to, any statements relating to our growth strategy and product
development programs and any other statements that are not historical facts. Forward-looking
statements are based on management’s current expectations and are subject to risks and uncertainties
that could negatively affect our business, operating results, financial condition and stock price. Factors
that could cause actual results to differ materially from those currently anticipated include: risks relating to
our growth strategy; government regulation; our ability to obtain, perform under and maintain financing
and strategic agreements and relationships; risks relating to the results of research and development
activities; uncertainties relating to preclinical and clinical testing; risks relating to the timing of starting and
completing clinical trials; our dependence on third-party suppliers; our ability to attract, integrate, and
retain key personnel; the early stage of products under development; our need for substantial additional
funds; patent and intellectual property matters; competition; as well as other risks described in the SEC
filings of Fortress Biotech, Inc. We expressly disclaim any obligation or undertaking to release publicly
any updates or revisions to any forward-looking statements contained herein to reflect any change in our
expectations or any changes in events, conditions or circumstances on which any such statement is
based, except as required by law.